The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
December 2019
in “
Trials
”
Research cited in this study
7 / 7 results
research A Medicinal and Edible Formula YH0618 Ameliorates the Toxicity Induced by Doxorubicin via Regulating the Expression of Bax/Bcl-2 and FOXO4
The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.
research A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.
research Chemotherapy-Induced Alopecia
Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.
research Chemotherapy-Induced Hair Loss
Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.
research Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies
Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.
research Hair Loss in Cancer Chemotherapy Patients
Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.
research Protection Against Chemotherapy-Induced Alopecia
No treatment fully prevents hair loss from chemotherapy yet.
Related Research
1 / 1 results
research Hair Loss
The document's conclusion about hair loss cannot be determined.